Thanks to the high-end vitamin ‘orthomol immun’, Dong-A Pharmaceutical’s 2Q results were driven

Reporter Paul Lee / approved : 2023-08-11 03:30:36
  • -
  • +
  • 인쇄

 

[Apha Biz=(Chicago) Reporter Paul Lee] Thanks to the High end vitamin 'Ortholol immun’, the company flew. The secret is thanks to a surge in sales of premium vitamins, Orthomol immun.

The industry points out that the key to the success of Orthomol is reducing distribution costs by using online distribution channels and word of mouth through celebrities such as celebrities.

Dong-A Pharmaceutical recorded sales of 163.2 billion won (145.1 billion won in the same period last year) and operating profit of 22 billion won (20.1 billion won) in the second quarter, up 18.1 billion won and 1.9 billion won from a year earlier, respectively.

Sales of its flagship Bacchus business unit reached 71.3 billion won in the second quarter, down 2.6 billion won from 73.9 billion won in the second quarter of last year. In addition, Dong-A Pharmaceutical was suspended from sales by the Ministry of Food and Drug Safety in April due to the browning of champ syrup.

In this situation, Osomol played a role as a good son. Sales in the Orthomol immun 2 quarter were 29.7 billion won, with cumulative sales reaching 57.5 billion won by the first half of the year. Sales in the first half reached KRW 65.5 billion last year.

Unlike ordinary vitamins, Orthomol immun is an expensive axis of 129,000 won (30 bottles). Nevertheless, the key to success is attributed to word of mouth such as growth through online distribution networks and celebrity nutrition. In fact, Orthomol immun was ranked No. 1 in Kakao gift sales in 2021, and also ranked No. 1 in the H&B store health functional food category from July 2021 to June 2022. In particular, it naturally attracted people's attention as it was known as vitamins used by famous actresses such as Kim Go-eun, Park Min-young and Jang Won-young.

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
Korea Zinc to Cancel All Treasury Shares by Year-End, Targeting Shareholder Return Ratio Above 200%2025.09.19
뉴스댓글 >

HEADLINE

건강이 보이는 대표 K Medical 뉴스

PHOTO

많이 본 기사